In addition, owing to the enriched amorphous feature, DPP95 and DPP90 deliver an improved orthogonal mobility (μh) of >0.01 cm2 V-1 s-1 under a 100% strain, higher than the value (∼0.002 cm2 V-1 s-1) of DPP100. Moreover, DPP95 even yields 20% enhanced orthogonal μh retention after 800 stretching-releasing cycles with 60% strain. As concluded from a series of analyses, the improved mobility-stretchability property exerted by random terpolymerization arises from the enriched amorphous feature and enhanced aggregation behavior imposed by the geometry mismatch between different acceptors (DPP and IID). This study demonstrates that backbone engineering through rational random terpolymerization not only enhances the mobility-stretchability of a conjugated polymer but also realizes a better mechanical endurance, providing a new perspective for the design of high-performance stretchable conjugated polymers.Multidomain bromodomain-containing proteins regulate gene expression via chromatin binding, interactions with the transcriptional machinery, and by recruiting enzymatic activity. Selective inhibition of members of the bromodomain and extra-terminal (BET) family is important to understand their role in disease and gene regulation, although due to the similar binding sites of BET bromodomains, selective inhibitor discovery has been challenging. To support the bromodomain inhibitor discovery process, here we report the first application of protein-observed fluorine (PrOF) NMR to the tandem bromodomains of BRD4 and BRDT to quantify the selectivity of their interactions with acetylated histones as well as small molecules. We further determine the selectivity profile of a new class of ligands, 1,4-acylthiazepanes, and find them to have ≥3-10-fold selectivity for the C-terminal bromodomain of both BRD4 and BRDT. Given the speed and lower protein concentration required over traditional protein-observed NMR methods, we envision that these fluorinated tandem proteins may find use in fragment screening and evaluating nucleosome and transcription factor interactions.Recent clinical and pathological evidence have implicated the gut microbiota as a nexus for modulating the homeostasis of the human body, impacting conditions from cancer and dementia to obesity and social behavior. The connections between microbiota and human diseases offer numerous opportunities in medicine, most of which have limited or no therapeutic solutions available. In light of this paradigm-setting trend in science, this review aims to provide a comprehensive and timely summary of the mechanistic pathways governing the gut microbiota and their implications for nanomedicines targeting cancer and neurodegenerative diseases. Specifically, we discuss in parallel the beneficial and pathogenic relationship of the gut microbiota along the gut-brain and gut-cancer axes, elaborate on the impact of dysbiosis and the gastrointestinal corona on the efficacy of nanomedicines, and highlight a molecular mimicry that manipulates the universal cross-β backbone of bacterial amyloid to accelerate neurological disorders. This review further offers a forward-looking section on the rational design of cancer and dementia nanomedicines exploiting the gut-brain and gut-cancer axes. The buccal fat pad also known as Bichat's fat pad has the same histological characteristics as fats located in other regions of the body, however, its particularity is the wrapping of a fibrous capsule that prevents it from being metabolized. learn more Bichectomy is the surgical procedure that partially removes oral fat, consequently it is possible to observe the volumetric reduction of the lower third of the face and the definition of contours and angulations, making the face aesthetically pleasing. However, this procedure is related to several potentially serious complications in the postoperative period due to the surgical technique. A bibliographic search was carried out based on scientific articles, published in English and Portuguese, between 2015 and 2019. The search was carried through the electronic databases PubMed, SciELO, Medline, Bireme and Lilacs with the keywords "bichectomy"; "Buccal fat pad"; "Buccal adipose tissue" and "Bichectomy and complications". Were included articles that reported the postoperative period and complications. The anatomical knowledge of this region is essential to avoid iatrogenesis in surgical procedures, which can result in temporary or permanent sequelae. Among the complications of greater complexity in bichectomy there are trismus, hemorrhages, facial infections, lesion of the duct of the parotid gland and facial paralysis, however common complications that are related to any surgical procedure can occur, such as edema and hematoma, despite being considered a technically simple procedure. Bichectomy is a quick and technically simple aesthetic-functional procedure, but it presents unpredictable risks of potentially serious complications.Bichectomy is a quick and technically simple aesthetic-functional procedure, but it presents unpredictable risks of potentially serious complications. An effective biomarker for the diagnosis of breast cancer (BC) and benign breast diseases (BBD) is crucial for improving the prognosis. We investigated whether N6-methyladenosine (m6A) can be a diagnostic biomarker of BC. We detected the contents of peripheral blood m6A in 62 patients with BC, 41 patients with BBD, and 41 normal controls (NCs) using the colorimetric method. The relative expression of the m6A regulated genes METTL14 and FTO was analyzed using quantitative real-time polymerase chain reaction. m6A in peripheral blood RNA was significantly higher in patients with BC than that in patients with BBD (p < 0.0001) or the NCs (p < 0.0001). m6A was closely associated with the disease stage (from stage 0 to stage I-Ⅳ; p = 0.003). The receiver operating characteristic curve of m6A contained an area under the curve (AUC) value of 0.887 in BC, which was greater than that of CEA or CA153. The combination of m6A, CEA, and CA153 improved the AUC to 0.914. The up- and downregulated mRNA expression of METTL14 and FTO, respectively, might contribute to the increase of m6A in patients with BC.